0 التعليقات
0 المشاركات
22 مشاهدة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
أخر الأخبار
- استكشف
-
الصفحات
-
المجموعات
-
المدونات
-
المنتديات
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة
-
Epidermal Growth Factor Receptor Inhibitor Market Global Industry Overview and ForecastThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 التعليقات 0 المشاركات 419 مشاهدة
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة
-
Tecentriq Market Industry Size and Emerging TrendsThe global oncology therapeutics industry is experiencing rapid advancement due to the increasing prevalence of cancer and the growing adoption of immunotherapy-based treatments. Tecentriq, an immunotherapy drug widely used in cancer treatment, has gained strong recognition for its effectiveness in managing various forms of cancer, including lung cancer and urothelial carcinoma. The increasing...0 التعليقات 0 المشاركات 363 مشاهدة
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek